spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  atherosclerotic plaque 

 HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 8 Nov 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Apr 2016
DalCor Pharmaceuticals Completes $150 Million Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 16 Mar 2015
Vascular Solutions Launches PolarCath(TM) Peripheral Dilatation System
Devices Interventional Product Launch
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 20 Nov 2013
MAQUET Cardiovascular Announces Study Results Demonstrating HEARTSTRING(R) Device Associated with Significant Reduction in Coronary Artery Bypass Stroke Risk
Devices Surgery Cardiology
 HSMN NewsFeed - 8 Jan 2013
AtheroNova Names New Clinical Affairs Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 18 Dec 2012
AtheroNova Names New Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 13 Jul 2012
ProTron's Cerebral Stethoscope Offers Breakthrough for Early Detection of Aneurysms
Devices
 HSMN NewsFeed - 29 Nov 2010
Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Increase in LDL-C and Safety Profile Similar to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics and Novasep Awarded 10.7 Million Funding from The French Government For the Development CER-001, An HDL Mimetic
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics raises 40 million in series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional
 HSMN NewsFeed - 27 Apr 2010
MAQUET Cardiovascular Announces Study Results Showing Significantly Reduced Stroke Rate In Coronary Artery Bypass Patients When Aortic Clamping is Avoided
Devices Cardiology Surgery
 HSMN NewsFeed - 7 Apr 2010
Recordati Signs Co-Marketing Agreement With Esteve in Spain for Pitavastatin
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 22 Dec 2009
The Medicines Company Acquires ApoA-I Milano From Pfizer
Biopharmaceuticals Licening
 HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Diagnostics Cardiology
 HSMN NewsFeed - 18 Jun 2009
Calcionics Appoints Daniel O. Wilds Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2009
VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 19 May 2009
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Oct 2008
Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
Devices
 HSMN NewsFeed - 10 Sep 2008
Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 2 Sep 2008
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Devices Cardiology
 HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 30 Mar 2008
Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Device That Clears Debris From Artery Aids Blood Flow in PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2007
Next Generation Devices to Treat Clogged Neck Arteries Launched in U.S. and Europe
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 9 Oct 2007
Indigo Pharmaceuticals Appoints Dennis R. Cryer as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Diagnostics Licensing
 HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 19 Apr 2007
QuantRx(R) Biomedical Acquires Majority Interest in FluoroPharma
Diagnostics Cardiology
 HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Feb 2007
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration
Devices Interventional FDA
 HSMN NewsFeed - 4 Dec 2006
ATS Medical Acquires Assets from EM Vascular
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2006
Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Nov 2006
Anesiva and Lumen Therapeutics Enter Agreement Granting Lumen Access to Data From Studies in Bypass Procedures
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Sep 2006
Merck and FoxHollow Technologies Expand Scope of Worldwide Strategic Research Collaboration
Devices Interventional Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2006
U.S. Food and Drug Administration Approves New Medical Devices to Treat Clogged Neck Arteries
Devices Interventional FDA
 HSMN NewsFeed - 13 Sep 2006
Abbott Announces European Launch of Next-Generation Device Designed to Treat Patients at Risk of Stroke
Devices Interventional
 HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 1 Jun 2006
Nuvelo Announces Completion of Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in Acute Coronary Syndromes
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 108

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 108 additional stories matching:
atherosclerotic plaque
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.